1. Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016;52:84–111.
2. Yang P, Ye Z, Du L, et al. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res. 2018;43(2):254–61.
3. Akpek EK, Jabs DA, Tessler HH, et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109(8):1506–13.
4. Nussenblatt RB, Whitcup SM, Palestine AG. Philosophy, goals, and approaches to medical therapy. Uveitis fundamentals and clinical practice. 2nd ed. St. Louis: Mosby-Year Book, Inc.; 1996. p. 97–134.
5. Baarsma GS, Caspers L, Cyclosporin A. In: Zierhut M, Pavesio C, Ohno S, et al., editors. Intraocular inflammation. Berlin: Springer; 2016. p. 331–8.